home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
  ABOUT IAS  | IAS LEADERSHIP  | MEMBER SOCIETIES  | MEMBERSHIP contact us  | home   

IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Organizations affiliated with the IAS.


IAS Statin Publication
Update Service


The International Atherosclerosis Society is very pleased to announce an exciting new and informative Newsletter for its membership: The IAS Statin Newsletter. The IAS will begin this month providing curated update on all publications involving statins as identified in PubMed.
For the Issues, click here

HDL Workshop


HDL Workshop:
Structure, novel functions and therapeutic applications

25-27 September 2019
Valencia, Spain


Scientific Program and Speakers

Abstract submission and Registration open now


Fellowship Awards
Winners 2018


Chiara Macchi
Milan, Italy


Dorothè Maria Kusters
Amsterdam, The Netherlands


Nerea Mendez Barbero
Madrid, Spain


Winner Reports
Winner 2016 - Blake Cochran
Winner 2016 - Ingo Hilgendorf
Winner 2016 - Yosdel Soto
Winner 2015 - Hagit Hochner
Winner 2015 - Kazuyuki Kasahara
Winner 2015 - Wei Tan
Winner 2014 - Amanda Foks
Winner 2014 - Nordin Hanssen
Winner 2014 - Marco Busnelli

last updated: March 13, 2019 

  From the IAS President's Desk


Raul Santos

It is with great honor that I start serving as President of the International Atherosclerosis Society (IAS) for the three-year term beginning in January 2019. Thinking of all that my predecessors accomplished, I realize the importance of the role I am assuming, and find it quite a challenging one.
The IAS aims to prevent cardiovascular disease, one of major causes of death worldwide, by playing important roles in coordinating the exchange of scientific information among the IAS constituent societies and fostering research on the prevention of atherosclerosis. In particular, the IAS has acted to foster education and communication globally among researchers, educators, and healthcare professionals in the field of atherosclerosis and cardiometabolic disorders.
Through the great efforts of the past presidents and many mentors, the IAS has kept growing and now is composed of 67 national and regional societies and has made many contributions to the successful prevention of cardiovascular disease in many countries. In addition, IAS has fostered collaboration with sister societies and entities that share the common goal of reducing cardiovascular disease. Read more


LET'S KEEP IN TOUCH
I am pleased to announce that the IAS is now on social media.
Facebook: https://www.facebook.com/atherosociety/
Twitter: https://twitter.com/atherosociety
LinkedIn: https://www.linkedin.com/groups/8689597/

Facebook  Twitter  Linkedin



  IAS - OSLA Collaboration in the MENA Region

The International Atherosclerosis Society (IAS) and Oman Society of Lipid & Atherosclerosis (OSLA) are organizing the Fifth IAS-OSLA Course "Lipid Metabolism and Cardiovascular Risk" to be held in Muscat, Oman, on February 8-11, 2019.
As in 2015, 2016, 2017 and 2018, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians practicing in the Middle East and North Africa (MENA) region who manage patients with lipid disorders.

We wish to thank all who submitted an application. We have received tens of them, all of very high standard. The selection has not been easy: at the end of the selection process 34 participants have been chosen, representative of almost all the MENA Region countries, with good male to female ratio and different specialty.
For the Scientific Program
The slide library of the Course is posted on the IAS website at the link: http://www.athero.org/iasosla2019/index.asp


  2nd Severe FH Course: Recognize, Diagnose, and Treat
 Severe Familial Hypercholesterolemia (Muscat, Oman, December 2-3, 2018)
2nd Severe FH Course
Raul Santos (President-Elect, IAS) and Khalid Al-Rasadi (President, OSLA) and was organized by the International Atherosclerosis Society (IAS), the Oman Society of Lipid and Atherosclerosis (OSLA), and the Gulf Heart Association Lipid Working Group (GHALWG). This interactive Course was accredited by the Oman Medical Specialty Board (OMSB) and was open to physicians practicing in the MENA Region.
IAS, OSLA, and GHALWG are happy to announce that the following material presented during the Course are available to our readers:

Scientific Program
Slide Library
Exclusive Interviews: Dr. Khalid AL-RASADI, Dr. Marcello ARCA, Dr. Raul SANTOS, Dr. Hani SABBOUR and Dr. Wolfgang RAMLOW



  IAS FH Activities

  XIX International Symposium on Atherosclerosis 2021

ISA2021 (Oman and Japan)
A very well attended booth was in place during the WCC2018 congress informing the participants about the ISA2021 Congress that will be held in Muscat, Oman on December 19-21, 2021 (pre-Satellite Symposium) and in Kyoto, Japan (October 24-27, 2021)

Photos of the IAS Booth

Pre-Satellite Symposium (Muscat, Oman, October 19-21, 2021)

ISA2021 Congress (Kyoto, Japan, October 24-27, 2021)


  XX International Atherosclerosis Society 2024 - Winner

We are pleased to announce that after the presentation of the outstanding bids for the ISA2024 Symposium from the Russian National Atherosclerosis Society (RNAS), Emirates Cardiac Society (ECS), Lipid Association of India (LAI), and Oman Society of Lipids & Atherosclerosis (OSLA) the IAS Executive Board during its meeting held in Toronto on June 9 has selected the winner of the ISA2024: the Oman Society of Lipids and Atherosclerosis (OSLA).


  IAS Commentaries

  Featured Connections

This website is a valuable source of information for the IAS members and the cardiovascular community. We draw your attention to the following featured connections. These are also listed (among others) in the left panel and include the following:

GUIDELINES A compilation of the guidelines on the prevention of atherosclerotic diseases published by several scientific Societies. These guidelines are readily available in pdf format or Power Point slides.

New additions: please check the latest guidelines: Brazilian FH guidelines.

CLINICAL TRIALS Abstracts of newly published clinical trials on atherosclerosis and the links to Pub Med, divided by topics and regularly updated. At the bottom of each trial abstract you will find a box where you can write your comments. Please limit your text to max 200 words. Your comments are encouraged.

E-NEWSLETTER AND E-LITERATURE The E-Newsletter provides a monthly update of the major activities of the IAS. The E-Literature lists the major articles published in the world's literature pertaining to atherosclerosis. It is a treasure trove of new scientific information.

STATIN NEWSLETTER The IAS is pleased to share with its readership this informative Newsletter: The IAS Statin Newsletter.
Statin publications have been targeted because of the fundamental role of statins as agents to reduce atherosclerotic cardiovascular disease (ASCVD) risk. The service aims to address the needs of health care professionals globally who manage patients with or at risk of developing ASCVD.

SLIDES The IAS provides slides obtained from previous IAS meetings and co-sponsored meetings. It also links to the slide collection of the Lorenzini Foundation and other organizations that make slides available over the internet.

LINKS The website links to a very large number of organizations and government agencies in fields related to atherosclerosis and cardiovascular medicine. It further links to key databases, libraries and journals.

VIEW RECENT PAPERS ON ATHEROSCLEROSIS BY COUNTRY Finally, the website includes all recent publications in the atherosclerosis field from each country represented by our member societies. Visit the Member Societies Page (see right panel) and click on the country of your choice.


  IAS Meetings and Educational Activities
To view all highlights, please click here

  Nonmember IAS Endorsed Activities
To view complete meeting schedule, please click here

  Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission:
Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Kaneka Europe, OSLA - Oman Society of Lipids and Atherosclerosis, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd.,Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College


Disclaimer - Cookie policy
This site is optimised for a min. 1024 x 768 pixels resolution

REGISTERED USER
USER ID


PASSWORD




Remember my password


Forgot your password?
Click here


First-time user?
Click here


WHO IS IAS

The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.

IAS Newsletter Editors & Website Editorial Board

Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta
Milan, Italy

Emanuela Folco
Milan, Italy

Ann Jackson
Houston, TX, USA

Commentary & Newsletter Editor
Yelonda Williams
(Dallas, TX, USA)

Elena Colombo
(Milan, Italy)